Sunflower Pharmaceutical: Will self-finance up to RMB 50 million to launch product research and development projects.

Kuihua Pharmaceutical announced that the 13th meeting of the 5th Board of Directors of the company approved the "Proposal on Product Research and Development Establishment", agreeing to self-fund up to 50 million yuan to carry out the research and development of traditional Chinese medicine with the same name and formula, the research and development of generic drugs for chemical drugs, and the addition of indications for existing products. At the same time, the management is authorized to control specific matters such as the progress of project research and development. This matter belongs to the authority of the board of directors and does not need to be submitted to the shareholders' meeting for approval.